Shares in the UK's biggest drug companies led the way on Wednesday, following news overnight that the US government had agreed its first deal on "most favoured nation" drug pricing with Pfizer. Toppi
- New clinical data across ten accepted abstracts demonstrate significant progress across Astellas' innovative oncology programs - - Results from the EV-303 trial (also known as KEYNOTE-905) in cispla
President Donald Trump, who has long argued that the U.S. pays more than it should for prescription medicines, on Tuesday said Pfizer had agreed to cut prices for drugs it sells to the Medicaid progra

Final Trade: PFE, PPH, CART, NKE

06:27pm, Tuesday, 30'th Sep 2025
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
The Trump administration announced a deal with pharmaceutical giant Pfizer (PFE) to lower drug prices while gaining an exemption from the president's tariff policies. Watch President Trump's remarks h
An agreement with the U.S. government and a favorable regulatory decision in Europe helped lift shares of large drugmakers. Meanwhile, the announcement of a collaboration that will integrate shopping
Market Domination host Josh Lipton breaks down the biggest market stories ahead of the closing bell on September 30, 2025. US lawmakers have failed to compromise on a deal and avert a government shutd
Gains in pharmaceutical stocks lifted indexes, despite the threat of an imminent government shutdown.
Metsera released data from mid-stage trials on its lead obesity drug candidate, while a high stakes Medicare open enrollment approaches.

3 Pharma Stocks Getting an Intraday Trump Bump

03:19pm, Tuesday, 30'th Sep 2025
Pharmaceutical stocks are enjoying tailwinds today, after President Donald Trump announced the launch of a direct-to-consumer website dubbed "TrumpRX.
Pfizer's stock surged after CEO Albert Bourla announces an agreement with the Trump administration aimed at lowering drug prices in the U.S. and removing tariff uncertainty.
CNBC's Angelica Peebles joins "The Exchange" to detail Pfizer's agreement with the Trump administration to voluntarily sell its medications at lower prices in the United States.
Pfizer CEO Albert Bourla, speaking in the Oval Office on Tuesday about the company's deal to lower drug prices, said the winner of the deal will "clearly will be the American patient." Bourla said the
Major U.S. equities indexes edged lower Tuesday afternoon, as a potential government shutdown loomed. The Dow, S&P 500, and Nasdaq were all slightly lower.
Shares of Pfizer rose about 5% after U.S. President Donald Trump said on Tuesday the drugmaker will cut the price on all of its prescription drugs sold to the Medicaid insurance program and will intro
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE